Obesity exacerbates many causes of death, but risks are different for men and women

October 24, 2019

People who carry around unhealthy amounts of weight don't just have heart disease and diabetes to worry about. Obesity is implicated in two thirds of the leading causes of death from non-communicable diseases worldwide and the risk of certain diseases differs for men and women. Cecilia Lindgren of the University of Oxford and colleagues report these findings in a new study published 24th October in PLOS Genetics.

As rates of obesity continue to grow worldwide, scientists have begun to suspect that excess weight might lead to or exacerbate other causes of death besides heart disease and type 2 diabetes. To identify additional causes of death made worse by obesity, researchers performed an analysis that explores cause-and-effect relationships using genetic data and three measures of obesity from 228,466 women and 195,041 men in the UK Biobank. Their analysis showed that obesity contributes to a laundry list of health problems including coronary artery disease, type 1 and 2 diabetes, stroke, chronic obstructive pulmonary disease, lung cancer, non-alcoholic fatty liver disease, chronic liver disease and kidney failure. While obesity causes type 2 diabetes in both women and men, women experienced a higher risk of type 2 diabetes as compared to men, while men faced a greater risk of chronic obstructive pulmonary disease and chronic kidney disease.

First author, Jenny Censin, said "this study shows just how harmful carrying excess weight can be to human health, and that women and men may experience different diseases as a result." Michael Holmes, who supervised the work together with Cecilia Lindgren, said "given the compelling evidence of harm that arises as a consequence of obesity across a broad range of diseases that result in death, our findings highlight the critical need for public health measures to stem the tide of obesity."

Overall, the study finds that obesity causes or contributes to the majority of the leading causes of death worldwide that are not linked to infectious diseases. The impacts of obesity, however, manifest differently in men and women. The findings have potential implications for the design of public health strategies and suggest that different preventative measures targeted at men and women may be warranted.
-end-
Peer-reviewed; Observational study; People

In your coverage please use this URL to provide access to the freely available article in PLOS Genetics: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1008405

Citation: Censin JC, Peters SAE, Bovijn J, Ferreira T, Pulit SL, Mägi R, et al. (2019) Causal relationships between obesity and the leading causes of death in women and men. PLoS Genet 15(10): e1008405. https://doi.org/10.1371/journal.pgen.1008405

Funding: JCC is funded by an NDM Prize Studentship (17/18_MSD_1108275) from the Oxford Medical Research Council Doctoral Training Partnership (Oxford MRC DTP; https://www.medsci.ox.ac.uk) and the Nuffield Department of Clinical Medicine (https://www.ndm.ox.ac.uk/), University of Oxford. SAEP is supported by a UK Medical Research Council Skills Development Fellowship (MR/P014550/1). JB is supported by funding from the Rhodes Trust (https://www.rhodeshouse.ox.ac.uk/), Clarendon Fund (https://www.ox.ac.uk/) and the Medical Sciences Doctoral Training Centre (https://www.medsci.ox.ac.uk/), University of Oxford. TF is supported by the NIHR Biomedical Research Centre, Oxford. SLP was funded by a Veni Fellowship (016.186.071; ZonMW; https://www.nwo.nl/) from the Dutch Organization for Scientific Research, Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) during the course of the study. MVH works in a unit that receives funding from the Medical Research Council (MRC; https://mrc.ukri.org/) and is supported by a British Heart Foundation Intermediate Clinical Research Fellowship (FS/18/23/33512; https://www.bhf.org.uk/) and the National Institute for Health Research Oxford Biomedical Research Centre (https://oxfordbrc.nihr.ac.uk). CML is supported by the Li Ka Shing Foundation (https://www.lksf.org/), WT-SSI/John Fell funds (https://researchsupport.admin.ox.ac.uk/), the National Institute for Health Research Biomedical Research Centre, Oxford (https://oxfordbrc.nihr.ac.uk/), Widenlife (H2020-TWINN-2015-692065; https://cordis.europa.eu/), and National Institute of Health (NIH; 5P50HD028138-27; https://www.nih.gov/). Computation used the Oxford Biomedical Research Computing (BMRC) facility, a joint development between the Wellcome Centre for Human Genetics and the Big Data Institute supported by Health Data Research UK and the NIHR Oxford Biomedical Research Centre, and with financial support provided by the Wellcome Trust Core Award Grant Number 203141/Z/16/Z. The funders had not role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: SLP has, since the writing of the article, started working for Vertex. MVH has collaborated with Boehringer Ingelheim in research, and in accordance with the policy of the Clinical Trial Service Unit and Epidemiological Studies Unit (University of Oxford), did not accept any personal payment. CML has collaborated with Novo Nordisk and Bayer in research, and in accordance with the policy of University of Oxford, did not accept any personal payment.

PLOS

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.